4//SEC Filing
Starling William N JR 4
Accession 0001209191-19-026322
CIK 0000876378other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 8:09 PM ET
Size
10.4 KB
Accession
0001209191-19-026322
Insider Transaction Report
Form 4
Starling William N JR
Director
Transactions
- Award
Stock Option Award
2019-04-25+29,104→ 29,104 totalExercise: $1.96Exp: 2029-04-25→ Common Stock (29,104 underlying) - Award
Common Stock
2019-04-25+20,380→ 20,380 total
Holdings
- 280,402(indirect: See Footnote)
Common Stock
- 235,738(indirect: See Footnote)
Common Stock
- 1,704,320(indirect: See Footnote)
Common Stock
Footnotes (6)
- [F1]Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
- [F2]The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
- [F3]Shares of Common Stock held by Synergy Life Science Partners, L.P. William N. Starling is a managing director of Synergy Life Science Partners, L.P.
- [F4]Shares of Common Stock held by Synecor, L.L.C. Willam N. Starling is the chief executive officer of Synecor, L.L.C.
- [F5]Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990.
- [F6]The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant.
Documents
Issuer
TRANSENTERIX INC.
CIK 0000876378
Entity typeother
Related Parties
1- filerCIK 0001324130
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 8:09 PM ET
- Size
- 10.4 KB